ETFs & Funds
View as an RSS Feed
An appeals court ruling yesterday that dismissed the conviction of a sales rep who sold a drug for non-FDA approved uses could have
for pharmaceutical companies, which have paid billions in fines for doing just that. Two out of three judges agreed with Alfred Caronia that his rights to free speech were violated. The government is expected to appeal the case, which could find its way to the Supreme Court.
View news story
The Physician always has the option of prescribing anything he/she feels will help the patient. As a result, they must have all of the possible information available to make that decision. Most often the Doctor relies on controlled scientific studies that prove efficacy of a particular therapy. The Sales Rep. facilitates this information, but does not promote unapproved uses.
Dec 4, 2012. 11:37 AM
Link to Comment